Navigation Links
Supercup Acetabular Cups

ProductsSupercup Acetabular Cups
Company Precision Instruments, Inc.
Item Supercup Acetabular Cups
Features Available in low profile, deep profile, and extra-deep profile (DP + 6 mm). Porous coated hemispherical cups all accommodate peripheral screw fixation and a choice of dome screws, no dome screws or pegs. Cups with peripheral screw capability are available in 39 mm diameter for CDH indication.
Description S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects.
Info Precision Instruments, Inc.
Customer Service:

Related medicine products :

1. Lineage Acetabular Ceramic Liners
2. Lineage Acetabular Metal Liners
3. Lineage Acetabular Poly Liners - 28 mm ID
4. Lineage Acetabular Poly Liners - 32 mm ID
5. Ringloc Acetabular Liners
6. Max-Rom Acetabular Liners
7. MARATHON Cross Linked Polyethylene Acetabular Liner
8. Oti Alfa Acetabular liners
9. Micro Seal Acetabular Liner
10. Trilogy Acetabular System
11. BiHAPro Acetabular Cup
Inquire
... autoimmune testing feature single-well ANA screen... tests including dsDNA, and 6 individual ENA kits:.... In addition, our autoimmune ELISA family include...gG, IgM), Thyroglobulin, Thyroid Microsomal, MPO, ...
... autoimmune testing feature single-well ANA screen... tests including dsDNA, and 6 individual ENA kits:.... In addition, our autoimmune ELISA family include...gG, IgM), Thyroglobulin, Thyroid Microsomal, MPO, ...
... autoimmune testing feature single-well ANA screen... tests including dsDNA, and 6 individual ENA kits:.... In addition, our autoimmune ELISA family include...gG, IgM), Thyroglobulin, Thyroid Microsomal, MPO, ...
Medicine Products:
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
...AGARA mudhala Ezhutthellam AADHI Bhagawan Mudattre...urral written by Thiruvalluvar somewhere around 30...hnology? // “ Annuvai Thulaithu Ezhkadalai Purati...uch is the ingenuity of its author, that he has co...
...apanese Pharmaceutical Company and Chinese Biotech...uction of drugs and clinical trials. The Japanese ...enomics. // The wet lab facilities and validation ...ina will be testing new lead compounds produced by...
...esearch shows that more and more women are now opt...ccording to a new study in the September issue of ...s for labor // and delivery become more varied and...bers of women are taking advantage of pain relief ...
...nsulin-like Growth Factor-1 (IGF-1) is an importan...e present in order for children's bones, cartilage...ls, growth hormone is // secreted into the bloodst...hormone receptors on liver and other cells, where ...
Other Medicine News:Health News:Scientists Consider About New Technology Called Nanotechnology 2
(Date:10/6/2008)...vere patients achieved endoscopic,response and mor... Week 10,in data from a 54-week open-label study p...gy (ACG) Annual Scientific Meeting, ORLANDO, Fla....from a,large, prospective study investigating endo...biologic compound. The data presented at the Ameri...
(Date:10/6/2008)...ny,s Bioabsorbable Stent - Also,Slated for Present.../ -- Data from multiple clinical trials of,the wor...Bio-engineered R,stent, will be presented next wee... symposium, TCT 2008, in Washington, D.C., Robber...Center in,Amsterdam will provide a Genous clinical...
(Date:10/3/2008)...-FirstCall/ -- deCODE genetics,(Nasdaq: DCGN ) to... drug,(IND) application for DG071, the company,s n... 4 (PDE4), with the US Food and Drug Administratio...and potentially safer means,of targeting PDE4 to c...d,with Alzheimer,s disease and other disorders in ...
(Date:10/2/2008)...aleads has obtained from the,French Medicine Agenc...ascending dose Phase I study with PL37, its lead c...Neuropathic pain is a major chronic pain condition...lation of up to 6%, according to the most,recent s... diabetes,antiviral or antitumor chemotherapy sur...
Breaking Medicine Technology:CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I 2Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference 5476 1Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference 5476 2Campbell Alliance Sales Practice to Present Workshop at SPBT Annual Conference 5476 3Adding epratuzumab to standard therapy 19583 1Adding epratuzumab to standard therapy 19583 2Top Academic Medical Centers Research Institutions and Partners Gather Share Experiences and Success Stories at Velos eResearch Annual Meeting 2102 1Top Academic Medical Centers Research Institutions and Partners Gather Share Experiences and Success Stories at Velos eResearch Annual Meeting 2102 2Top Academic Medical Centers Research Institutions and Partners Gather Share Experiences and Success Stories at Velos eResearch Annual Meeting 2102 3Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 1Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 2Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 3Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 4Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 5Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 6Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 7Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 8Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 9Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 10Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 11Shengtai Pharmaceutical Inc Reports Third Quarter Results of Fiscal Year 2008 19578 12
...bodies Inhibited Tumor Growth By, ...grine,s Antibodies that Selectively Inhibit VEGF R... Non-Selective Approaches - , - These Results Alon...pport , Advancing Peregrine,s Anti-VEGF Program to...Calif., April 16, 2007,/PRNewswire-FirstCall/ -- P...
...swire-FirstCall/ --,Threshold Pharmaceuticals, Inc...ng its oncology pipeline, which includes two,precl...Prodrug,TH-302, and two research presentations fr...entations will take place at the 2007,American Ass...,being held April 14 - 18, 2007, at the Los Angele...
Other Medicine Technology:Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 2Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 3Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 4Data Presented at AACR Meeting Shows Peregrine's Selective,Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical,Cancer Models 5Threshold Pharmaceuticals Announces Multiple Presentations on,Oncology Pipeline at the 2007 American Association for Cancer,Research (AACR) Annual Meeting 2Threshold Pharmaceuticals Announces Multiple Presentations on,Oncology Pipeline at the 2007 American Association for Cancer,Research (AACR) Annual Meeting 3